Intravesical High Dose BCG Tokyo and Low Dose BCG Tokyo with GMCSF+IFN α  Induce Systemic Immunity in a Murine Orthotopic Bladder Cancer Model. Here, IFNA1 is linked to urinary bladder cancer.